Heron Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Heron Therapeutics Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Heron Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Heron Therapeutics Inc.

Back to companies

Heron Therapeutics Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Heron Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP3193830B1 Grant Emulsion d'aprepitant A61K47/24; A61K47/26; A61K47/10; A61K47/44; A61K47/12; A61K47/18; A61P1/08; A61K9/107; A61K9/0024; A61K31/5377; A61P43/00; A61K31/573; A61K9/0019 November 01, 2023
US11744800B2 Grant Methods of use of emulsion formulations of an nk-1 receptor antagonist A61K31/43; A61K31/435; A61K31/496; A61K31/5377; A61K31/573; A61K47/10; A61K47/24; A61K47/44; A61K9/0019; A61K9/1075; G06F16/90344; G06F16/9038; G06N20/00; G06N3/126; G06N5/01; G06N5/025; G06N5/045; G06N7/01 September 05, 2023
AU2023202876A1 Application Long-acting polymeric delivery systems A61P23/02; A61P25/04; A61P29/00; A61K47/12; A61K47/14; A61P17/02; A61P23/00; A61P43/00; A61P1/08; A61K9/0019; A61K31/00; A61K31/5415; A61K9/08; A61K47/32; A61K31/245; A61K47/20; A61K2300/00; A61K31/196; A61K31/445; A61K9/0085; A61K9/127; A61K31/167; A61K47/34; A61K31/46; A61K45/06; A61K9/0024; A61K9/14; A61K9/06; A61P25/02 May 25, 2023
BR112016024665B1 Grant Composição, composição semissólida e seu uso A61P43/00; A61P17/02; A61P23/00; A61K45/06; A61K47/14; A61P25/02; A61K47/32; A61K31/46; A61P23/02; A61K9/06; A61K31/5415; A61K47/34; A61K9/0019; A61P25/04; A61P29/00; A61K9/0024; A61K9/14; A61K31/00; A61K31/245; A61P1/08; A61K2300/00; A61K31/167; A61K31/445; A61K47/20; A61K9/08; A61K9/0085; A61K31/196; A61K47/12; A61K9/127 April 11, 2023
US20230072781A1 Application Methods of use of emulsion formulations of an nk-1 receptor antagonist A61K31/43; A61K31/435; A61K31/496; A61K31/5377; A61K31/573; A61K47/10; A61K47/24; A61K47/44; A61K9/0019; A61K9/1075; G06F16/90344; G06F16/9038; G06N20/00; G06N3/126; G06N5/01; G06N5/025; G06N5/045; G06N7/01 March 09, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer